Contact:
Yale Office of Cooperative Research
203-785-6209
biohaven@yale.edu
Description:
Biopharma industry and legal experts will analyze the recent Supreme Court decision regarding the Affordable Care Act and explain how implementation of the ACA will affect new medicine and medical device R&D and pricing, as well as life sciences innovation generally. Moderated by Paul Pescatello, CURE (Connecticut United for Research Excellence).
You're Almost Done!
Select a display name and password
{* #socialRegistrationForm *} {* socialRegistration_displayName *} {* socialRegistration_emailAddress *} {* traditionalRegistration_password *} {* traditionalRegistration_passwordConfirm *}Tell us about yourself
{* registration_firstName *} {* registration_lastName *} {* registration_postalZip *} {* registration_birthday *} {* registration_gender *} {* agreeToTerms *}